JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Abstract Details

Activity Number: 515
Type: Contributed
Date/Time: Wednesday, August 1, 2012 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract - #306307
Title: Analysis of Time-to-Event Data with Categories of Response
Author(s): Beiying Ding*+ and Chunlei Ke
Companies: Amgen, Inc. and Amgen, Inc.
Address: , , ,
Keywords: time-to-event ; proportional odds ; severity

Time-to-event endpoints are frequently encountered in clinical trial data. When event times are observed, additional information concerning the type or severity of event is often recorded. For example, in patients with non-metastatic cancer, the first bone metastasis at time of detection could be asymptomatic (i.e. bone lesion only present in bone scan) or also accompanied by symptoms such as bone pain. When evaluating different treatment options, this level of information may prove to be valuable especially if treatment is more effective in preventing event of certain level(s) of severity that is clinically more meaningful. Different analysis strategies are explored in this context including time-varying proportional odds model, continuation ratio model and competing risk models with ordinal response categories. Pros and cons of different approaches under various assumptions of the treatment effect pattern related to the severity of the event as well as potential generalizations will also be discussed.

The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2012 program

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.